EKG — CardioComm Solutions Cashflow Statement
0.000.00%
- CA$0.99m
- CA$1.63m
- CA$0.27m
Annual cashflow statement for CardioComm Solutions, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0 | -0.002 | -0.097 | -0.195 | -0.529 |
| Depreciation | |||||
| Non-Cash Items | 0.224 | 0.021 | -0.002 | 0.035 | 0.045 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.373 | 0.007 | 0.021 | 0.02 | 0.003 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.121 | 0.055 | -0.054 | -0.111 | -0.453 |
| Capital Expenditures | -0.003 | -0.01 | -0.002 | -0.005 | -0.003 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.003 | -0.01 | -0.002 | -0.005 | -0.003 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.109 | -0.096 | 0.091 | 0.089 | 0.439 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.014 | -0.051 | 0.035 | -0.027 | -0.017 |